Cargando…

Application and prospect of trabecular bone score in differentiated thyroid cancer patients receiving thyrotropin suppression therapy

Thyroid-stimulating hormone (TSH) suppression therapy is one of the common treatments for most patients with differentiated thyroid cancer (DTC). Unfortunately, its detrimental effects on bone health are receiving increasing attention. It may increase the risk of osteoporosis and osteoporotic fractu...

Descripción completa

Detalles Bibliográficos
Autores principales:	Ran, Bingyu, Wei, Feng, Gong, Jian, Xu, Hao
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2022
Materias:	Endocrinology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9596913/ https://www.ncbi.nlm.nih.gov/pubmed/36313757 http://dx.doi.org/10.3389/fendo.2022.1004962

Ejemplares similares

Effect of Thyrotropin Suppression Therapy on Bone in Thyroid Cancer Patients
por: Papaleontiou, Maria, et al.
Publicado: (2016)

Trabecular Bone Score in Women With Differentiated Thyroid Cancer
por: Araujo Sousa, Barbara Erika Caldeira, et al.
Publicado: (2021)

Trabecular Bone Score and Osteoprotegerin as Useful Tools in the Assessment of Bone Deterioration in Acromegaly
por: Jawiarczyk-Przybyłowska, Aleksandra, et al.
Publicado: (2022)

The risk between thyrotropin suppression and bone mineral density in differentiated thyroid cancer
por: Zou, Yang, et al.
Publicado: (2022)

Decreased Trabecular Bone Score in Patients With Active Endogenous Cushing’s Syndrome
por: Stachowska, Barbara, et al.
Publicado: (2021)

Trabecular bone score and sclerostin concentrations in patients with primary adrenal insufficiency
por: Zdrojowy-Wełna, Aleksandra, et al.
Publicado: (2022)

Age-based factors modulating the required thyroxine dose to achieve thyrotropin suppression in intermediate-and high-risk papillary thyroid cancer
por: Zhou, Ruo-Yun, et al.
Publicado: (2023)

Thyrotropin Stimulates Differentiation Not Proliferation of Normal Human Thyrocytes in Culture
por: Morgan, Sarah J., et al.
Publicado: (2016)

Commentary: Thyrotropin Stimulates Differentiation Not Proliferation of Normal Human Thyrocytes in Culture
por: Kyrilli, Aglaia, et al.
Publicado: (2017)

Effects of thyrotropin suppression on lumbar bone mineral density in postmenopausal women with differentiated thyroid carcinoma
por: Zhang, Pei, et al.
Publicado: (2018)

Risk Factors for Predicting Osteoporosis in Patients Who Receive Thyrotropin Suppressive Levothyroxine Treatment for Differentiated Thyroid Carcinoma
por: Soydal, Çiğdem, et al.
Publicado: (2019)

Serum Thyrotropin and Phase of the Menstrual Cycle
por: Benvenga, Salvatore, et al.
Publicado: (2017)

β-Arrestin 1 in Thyrotropin Receptor Signaling in Bone: Studies in Osteoblast-Like Cells
por: Boutin, Alisa, et al.
Publicado: (2020)

Trabecular bone score and phalangeal quantitative ultrasound are associated with muscle strength and fracture risk in hemodialysis patients
por: Catalano, Antonino, et al.
Publicado: (2022)

THU231 Thyroid Function And Childhood Bone Mineral Density: Abnormal Thyrotropin Concentration May Be Another Predictor Of Pediatric Low Bone Mass
por: Ahn, Moon Bae
Publicado: (2023)

Measurements of Bone Health after Thyroid-Stimulating Suppression Therapy in Postmenopausal Women with Differentiated Thyroid Carcinoma: Bone Mineral Density versus the Trabecular Bone Score
por: Chung, Chae Won, et al.
Publicado: (2021)

Review on the Utility of Trabecular Bone Score, a Surrogate of Bone Micro-architecture, in the Chronic Kidney Disease Spectrum and in Kidney Transplant Recipients
por: Shevroja, Enisa, et al.
Publicado: (2018)

Differential Regulation of the Expression of the Two Thyrotropin Beta Subunit Paralogs by Salmon Pituitary Cells In Vitro
por: Fleming, Mitchell Stewart, et al.
Publicado: (2020)

Abnormal Trabecular Bone Score, Lower Bone Mineral Density and Lean Mass in Young Women With Premature Ovarian Insufficiency Are Prevented by Oestrogen Replacement
por: Samad, Navira, et al.
Publicado: (2022)

Can Thyrotropin, Tri-Iodothyronine, and Thyroxine Hormones be Predictors of Cancer in Thyroid Lesions?
por: Khider, Mohamed O, et al.
Publicado: (2022)

Age, body composition parameters and glycaemic control contribute to trabecular bone score deterioration in acromegaly more than disease activity
por: Ságová, Ivana, et al.
Publicado: (2023)

Taltirelin is a superagonist at the human thyrotropin-releasing hormone receptor
por: Thirunarayanan, Nanthakumar, et al.
Publicado: (2012)

Thyrotropin Receptor Epitope and Human Leukocyte Antigen in Graves’ Disease
por: Inaba, Hidefumi, et al.
Publicado: (2016)

The Role of Thyrotropin Receptor Activation in Adipogenesis and Modulation of Fat Phenotype
por: Draman, Mohd Shazli, et al.
Publicado: (2017)

Tanycytes and the Control of Thyrotropin-Releasing Hormone Flux Into Portal Capillaries
por: Rodríguez-Rodríguez, Adair, et al.
Publicado: (2019)

Stimulatory Thyrotropin Receptor Antibodies Are a Biomarker for Graves’ Orbitopathy
por: George, Augustine, et al.
Publicado: (2021)

Benign thyroid nodules respond to a single administration of 0.3mg recombinant human thyrotropin with highly variable volume increase
por: Bountouris, Panagiotis, et al.
Publicado: (2023)

Structure Model Index Does Not Measure Rods and Plates in Trabecular Bone
por: Salmon, Phil L., et al.
Publicado: (2015)

Neuropilin 2 in osteoblasts regulates trabecular bone mass in male mice
por: Verlinden, Lieve, et al.
Publicado: (2023)

Concurrent Graves' Disease and TSH Secreting Pituitary Adenoma Presenting Suppressed Thyrotropin Levels: A Case Report and Review of the Literature
por: Fu, Jinrong, et al.
Publicado: (2020)

Trabecular bone deterioration in differentiated thyroid cancer: Impact of long‐term TSH suppressive therapy
por: Hawkins Carranza, Federico, et al.
Publicado: (2020)

Therapy With Intravenous Methylprednisolone Pulses Is Associated With Loss of Bone Microarchitecture in Trabecular Bone Score -Assessment Among Patients With Moderate-to-Severe Graves’ Orbitopathy: A Pilot Study
por: Rymuza, Joanna, et al.
Publicado: (2022)

Association of Thyrotropin Suppression With Survival Outcomes in Patients With Intermediate- and High-Risk Differentiated Thyroid Cancer
por: Klubo-Gwiezdzinska, Joanna, et al.
Publicado: (2019)

Erratum: Structure Model Index Does Not Measure Rods and Plates in Trabecular Bone
Publicado: (2015)

Glucocorticoids and Trabecular Bone Score
por: Sandru, Florica, et al.
Publicado: (2020)

Update on trabecular bone score
por: Palomo, Telma, et al.
Publicado: (2022)

Application of the Trabecular Bone Score in Clinical Practice
por: Kong, Sung Hye, et al.
Publicado: (2021)

Thyrotropin Regulates eNOS Expression in the Endothelium by PGRN Through Akt Pathway
por: Jiang, Fengwei, et al.
Publicado: (2018)

Assessment of Osteoporosis in Lumbar Spine: In Vivo Quantitative MR Imaging of Collagen Bound Water in Trabecular Bone
por: Liu, Jin, et al.
Publicado: (2022)

Resolving trabecular metaphyseal bone profiles downstream of the growth plate adds value to bone histomorphometry in mouse models
por: Salmon, P. L., et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_qo1eas8igj9cqfj74ati5bnct5